medisourceasia.com

Industry News


Home

About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

Cardiac Completes Certification For HeartCentrix With NextGen

Cardiac Science Corporation, a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, said it completed certification for its HeartCentrix ECG informatics software with NextGen Healthcare Information Systems. NextGen is a leading developer and provider of computer based practice management and electronic medical record (EMR) systems for medical group practices and healthcare systems.

Featuring the industry's most robust cardiology knowledgebase, the NextGen EMR system is used by more than 1,500 clients nationwide including many leading cardiology practices. These current clients, as well as future clients, will be readily able to take advantage of connectivity to the HeartCentrix informatics software. In addition, the integration will be leveraged through the tens of thousands in Cardiac Science's installed base of customers.

Designed to integrate seamlessly EMR and other information systems, HeartCentrix solutions help streamline workflow in multiple health care environments. HeartCentrix which enables seamless data transfer from Burdick and Quinton electrocardiograph (ECG) devices, cardiac stress, and Holter monitoring devices to physician EMR software can be installed with a new NextGen EMR implementation, or just as easily into an existing NextGen account.

Tony Titus, vice president, marketing, Cardiac Science, said, "HeartCentrix and NextGen recently began deployment for their first joint installation, a multi site cardiology practice of more than 60 physicians. Pairing HeartCentrix with NextGen connects diagnostic devices and EMR systems together for officewide efficiencies, and a greater ROI on the EMR investment."

(Ref: The Chronicle Pharmabiz dated April 10, 2008)


Dow Reveals Health and Hygiene Product Applications for INFUSE™ Olefin Block Copolymers at INDEX 08

This week Dow delivers a series of technical presentations at the INDEX 08 exhibition in Geneva detailing how its INFUSE™ Olefin Block Copolymers (OBCs) can create powerful new product application opportunities for brand owners and converters in the health and hygiene market segment. INFUSE OBCs, one of Dow’s latest resin product families, are an exciting development in olefin elastomers because of a distinct block architecture that delivers excellent new combinations of resin performance and processing properties.

“The advantages of INFUSE OBCs can help health and hygiene brand owners to differentiate their products and optimize cost-in-use compared to traditional elastomer materials,” said Carlos Ruiz, Global Market Director for Health and Hygiene, The Dow Chemical Company. “As our presentations here have shown, they are well positioned for use in extensible and elastic components of health and hygiene products, such as the ears, side panels, back and top sheets, waist bands, leg cuffs and closure systems of diapers and adult incontinence products. They are also excellent for use in non-wovens for medical garments, hospital disposables and wipes, and as hot melt and pressure sensitive adhesives in health and hygiene products.”

Invented using INSITE™ Technology -- Dow’s approach to linking the science of catalyst, process and materials together to address customer needs -- INFUSE OBCs offer several distinct attributes versus currently available polyolefin elastomers. These attributes include improved balance of flexibility and high temperature resistance; faster set-up in processing due to higher crystallization temperature; enhanced elastic recovery and compression set properties at both ambient and elevated temperatures; and improved abrasion resistance.

Dow is a leading global supplier of plastics and performance chemicals for the health and hygiene industry, improving comfort and quality of life through innovations in materials science for suppliers and users of diapers, feminine hygiene products, medical disposables, technical nonwovens, wipes and protective garments. Dow’s advanced and comprehensive portfolio includes products which are used to help manufacture water vapor permeable and breathable hygiene films that virtually prevent heat build-up and rash; films, foams, and fibers to produce comfortable and form-fitting products; and light and ultra-efficient absorbent cores, such as polymeric absorbent cores.

(Reference: Webwire: April 17, 2008, Link: http://www.webwire.com/ViewPressRel.asp?aId=63507 )


Next
 

Other News

Fresenius Net Income Surges By 24% In 2007 At Euro 11,358 Million
Govt to issue new guidelines for medical device industry
India No More Hot Offshore R&D Centre
Bigtec Invests Rs. 10 Cr For Advanced Biotech Lab At IISc Campus
Marck To Enter Malaysia, S’pore & Indonesia Markets
RG Stone Urology Plans Telemedicine, Satellite Centres In India
Medical Equipment Cos Ask Govt To Bring Down Import Duty To 5% In Union Budget
J&J expands its presence in orthopaedics
Transasia Bio-Medicals Ltd. gets ISO 13485

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next